European Commission study shows 5% leap in European industrial R&D spending

The 2006 EU Industrial R&D Investment Scoreboard shows that the top 1000 EU companies increased their R&D by an average of 5.3 % in 2005. This figure is in line with the results of a Commission survey released earlier this year. The top 1000 non-EU companies raised their R&D investment by 7.7%, showing a world-wide boost in R&D spending. The EU maintains a high profile, with 18 of the top 50 R&D spenders and 5 of the 10 word-wide companies with the fastest R&D growth. These figures emerge from the analysis of the top 1000 EU and 1000 non-EU companies investing in R&D. The full report, including detailed sector-by-sector analysis will be available later this year.

Janez Potočnik, European Commissioner for Science and Research said "This year's R&D scoreboard is very encouraging. If this trend continues, we could gradually close the R&D investment gap. I hope that at the Lahti summit later this month, European leaders will support the Commission's proposals to go further to boost innovation in Europe, and give even more impetus to these positive developments."

After a period of sluggish R&D growth, this year's scoreboard shows a strong increase in R&D investment worldwide. An average growth rate for EU companies of 5.3% contrasts with last year's growth rate for 0.7% and a contraction of 2% in 2004. The R&D investment growth of companies in the rest of the world in 2005 was 7.7%, one percent higher than the previous year.

The EU companies continue to perform well among the top R&D investors. Of the worldwide top 50, 18 are EU companies, the same number as last year, including 5 of the 10 fastest R&D growth companies worldwide. From the rest of the world, the top 50 includes 18 US companies, 10 Japanese (2 less than last year), 2 Swiss and 2 South Korean (the 2006 Scoreboard reports high R&D growth by South Korean companies). Most of top R&D investors are from automobile & parts sector (13 companies), pharmaceuticals (11 companies) and IT Hardware (9 companies). Daimler-Chrysler is once again the biggest R&D investor among EU companies.

This year, the Scoreboard includes a larger proportion of companies from sectors showing high R&D growth rates, especially in the EU group, where the presence of companies in R&D-intensive sectors such as software & computer services and pharmaceutical & biotechnology has increased.

The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (DG RTD and DG JRC-IPTS) as part of its Industrial Research Investment Monitoring (IRIM) activity. The number of companies in the Scoreboard increased from 1400 last year to 2000 in the present edition. Together, the 1000 companies from the EU and the 1000 from outside invested €371 billion in R&D, estimated to represent more than half of world corporate R&D investment.

Details of all 2000 companies including R&D and financial data and in-depth analysis of the data are available from http://iri.jrc.es. An in-depth analysis of the data will be published before the end of the year.

© European Communities, 2006

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...